tiprankstipranks
Trending News
More News >
Lion Corporation (JP:4912)
:4912

Lion (4912) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4912

Lion

(OTC:4912)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 4o)
Rating:76Outperform
Price Target:
¥1,923.00
▲(15.08% Upside)
Lion's strong financial performance and bullish technical indicators are the primary drivers of its stock score. The company's solid revenue growth and stable financial position are complemented by positive market momentum. While the valuation is fair, the lack of recent earnings call data and corporate events limits additional insights.
Positive Factors
Revenue Growth
Strong revenue growth indicates effective market strategies and product demand, supporting long-term business expansion and market position.
Cash Flow Generation
Improved cash flow generation enhances financial flexibility, allowing for reinvestment in growth opportunities and debt reduction.
Balance Sheet Health
A strong balance sheet with low leverage reduces financial risk and supports sustainable growth and investment capacity.
Negative Factors
Declining ROE
A declining ROE may indicate challenges in efficiently generating returns on equity, potentially impacting investor confidence and growth.
Net Profit Margin Decrease
A decreasing net profit margin suggests rising costs or pricing pressures, which could affect profitability if not addressed.
Free Cash Flow Efficiency
Reduced free cash flow efficiency may limit the company's ability to fund operations and growth initiatives, impacting long-term financial health.

Lion (4912) vs. iShares MSCI Japan ETF (EWJ)

Lion Business Overview & Revenue Model

Company DescriptionLion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through three segments: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers dental and oral care products, including toothpastes, toothbrushes, dental floss, dental rinses, mouthwashes and breath fresheners, periodontitis ointments, and denture products; body care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, body washes, skin and acne care products, antiperspirants and deodorants, hair-nourishment treatments, men's care and toiletries products, and foot care products. It also provides antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, topical anti-inflammatory analgesics, antidiarrheal and gastrointestinal medicines, health tonic drinks and vitamin supplements, acne and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care products, such as laundry detergent, delicate detergent, prewash treatment, stain remover, bleach, and fabric softener; clothing care products; household cleaners; kitchen cleanup products comprises dishwashing detergents and antibacterial and deodorizing products; and food preparation products. Further, it provides health and beauty food products consisting of supplements and health tonic drinks; specialty chemicals, and chemical products, include rubber processing and additive agents, mandrel release agents, fatty acid methyl esters, plant-based electrical insulating oils, concrete admixtures, ground improvement and asphalt recycling agents, surfactants, and cosmetics ingredients, as well as electro-conductive carbon black and pressure-sensitive adhesives; pet supplies; and gift and special order products. The company was founded in 1891 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyLion generates revenue through multiple streams, primarily from the sale of its food and beverage products. Key revenue streams include the sale of dairy products, alcoholic beverages, and nutritional goods, which are distributed through both retail channels and direct sales to businesses. Lion has established significant partnerships with retailers and distributors, enhancing its market reach and brand visibility. Additionally, the company benefits from economies of scale in production and a strong supply chain, which contribute to its profitability. Seasonal promotions and product innovation also play a crucial role in driving sales and increasing consumer engagement.

Lion Earnings Call Summary

Earnings Call Date:Nov 07, 2024
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Feb 12, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted an increase in net sales and profits, driven by effective price revisions and structural reforms. However, challenges such as impairment losses, a decline in domestic sales, and a slowdown in certain overseas markets were also noted. The partnership with Japan Activation Capital is a strategic move to bolster future growth.
Q3-2024 Updates
Positive Updates
Increased Net Sales and Profits
Net sales were JPY 301.1 billion, up 1.7% year-on-year. Core operating income was JPY 18.6 billion, an increase of JPY 6 billion year-on-year.
EBITDA Growth
EBITDA was JPY 32.5 billion, up JPY 6.4 billion year-on-year, with an EBITDA margin increase of 2 percentage points to 10.8%.
Price Revision and Profit Structure Reform
Price revisions led to JPY 2.8 billion in increased profits. The company plans to achieve JPY 4 billion in price revisions by the end of the year.
Overseas Business Performance
Double-digit growth in overseas sales. Thailand grew 1.1%, Malaysia 8.2%, China 9.2%, and South Korea 5.2% in local currency terms.
Partnership with Japan Activation Capital
Announced a partnership with Japan Activation Capital to support management policy strategy and enhance execution speed.
Negative Updates
Impairment Loss on Domestic Facilities
Impairment loss of approximately JPY 6.2 billion due to streamlining of domestic home care production facilities.
Challenges in Fabric Care
Fabric Care business has been in the red due to CapEx and promotion costs, but structural reform is expected to return it to profitability.
Sales Decline in Domestic Consumer Products
Domestic consumer product sales declined by 4.3% due to a reactionary downturn from a previous year's new product launch.
Moderate Growth in Overseas Markets
Growth has slowed down in Southeast and South Asia and Northeast Asia compared to the first half of the year.
Economic Slowdown in China
Chinese economy showing signs of slowing, impacting existing stores, though new distribution networks are expanding.
Company Guidance
In the earnings call for Q3 2024, Lion Corporation reported a 1.7% increase in net sales to JPY 301.1 billion, with a core operating income rise of JPY 6 billion year-on-year, reaching JPY 18.6 billion. The EBITDA was JPY 32.5 billion, up by JPY 6.4 billion, with a margin increase of 2 percentage points to 10.8%. Despite an impairment loss of JPY 6.2 billion due to domestic production facility streamlining, the company maintained its full-year forecast, attributing the resilient performance to price revisions and cost reductions, specifically mentioning a JPY 2.8 billion price revision impact and a total cost reduction of JPY 2.2 billion. The consumer product sales in Japan fell by 4.3%, whereas overseas sales showed sustained double-digit growth. The company plans further asset sales in Q4 to support ongoing structural reforms, aiming for a total shareholder return ratio of 91.9% with a dividend set at JPY 27 per share.

Lion Financial Statement Overview

Summary
Lion exhibits strong profitability and a robust balance sheet with low leverage. However, the recent decline in revenue and free cash flow growth in the TTM period presents potential challenges. The company maintains operational efficiency, but the focus should be on reversing the revenue and cash flow trends to sustain long-term growth.
Income Statement
85
Very Positive
Lion's income statement shows a stable gross profit margin of around 45% over the years, indicating efficient cost management. However, the TTM data reveals a revenue decline of 10.8%, which is concerning. The net profit margin remains modest at 5.2% in the TTM, reflecting consistent profitability, though slightly lower than previous years. EBIT and EBITDA margins are stable, suggesting operational efficiency. Overall, while profitability is stable, the recent revenue decline is a potential risk.
Balance Sheet
78
Positive
Lion maintains a strong balance sheet with a low debt-to-equity ratio of 0.10 in the TTM, indicating low financial leverage and reduced risk. The return on equity is moderate at 7.5%, showing decent profitability relative to shareholder equity. The equity ratio is healthy, reflecting a strong capital structure. Overall, the balance sheet is robust, with low leverage and solid equity positioning.
Cash Flow
80
Positive
The cash flow statement shows a decline in free cash flow growth by 30.8% in the TTM, which is a concern. The operating cash flow to net income ratio is 0.34, indicating adequate cash generation relative to net income. The free cash flow to net income ratio is 0.52, suggesting reasonable cash flow conversion. While cash flow generation is adequate, the significant decline in free cash flow growth poses a risk.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue416.73B412.94B402.77B389.87B366.23B355.35B
Gross Profit190.35B188.78B180.60B174.61B179.10B179.87B
EBITDA60.84B49.55B43.42B47.31B46.06B56.37B
Net Income29.35B21.20B14.62B21.94B23.76B29.87B
Balance Sheet
Total Assets480.31B497.17B486.36B469.28B428.02B435.50B
Cash, Cash Equivalents and Short-Term Investments62.52B102.24B85.53B101.08B97.25B121.53B
Total Debt28.63B29.74B30.34B32.17B8.37B8.12B
Total Liabilities151.34B181.47B188.23B190.11B163.01B190.65B
Stockholders Equity305.92B293.72B280.32B264.25B251.57B231.72B
Cash Flow
Free Cash Flow19.57B25.60B5.08B18.82B-23.63B13.80B
Operating Cash Flow38.29B43.66B30.07B41.96B19.30B40.73B
Investing Cash Flow-38.78B-7.66B-34.79B-19.54B-34.18B-19.87B
Financing Cash Flow-12.37B-21.20B-11.76B-19.82B-10.22B-9.14B

Lion Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1671.00
Price Trends
50DMA
1584.01
Positive
100DMA
1578.58
Positive
200DMA
1604.59
Positive
Market Momentum
MACD
20.43
Negative
RSI
69.26
Neutral
STOCH
83.13
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4912, the sentiment is Positive. The current price of 1671 is above the 20-day moving average (MA) of 1635.20, above the 50-day MA of 1584.01, and above the 200-day MA of 1604.59, indicating a bullish trend. The MACD of 20.43 indicates Negative momentum. The RSI at 69.26 is Neutral, neither overbought nor oversold. The STOCH value of 83.13 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4912.

Lion Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥157.46B19.615.04%1.41%0.75%
76
Outperform
¥449.85B15.629.77%1.75%2.18%60.81%
72
Outperform
¥80.56B24.406.83%3.59%3.05%-32.61%
71
Outperform
¥593.17B16.2113.22%1.60%18.35%31.87%
68
Neutral
¥294.90B29.526.05%3.90%-1.16%36.30%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
¥390.17B33.915.37%1.96%-3.33%13.76%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4912
Lion
1,703.00
-50.69
-2.89%
JP:4967
Kobayashi Pharmaceutical Co
5,255.00
-598.31
-10.22%
JP:4919
Milbon Co
2,450.00
-974.72
-28.46%
JP:4927
Pola Orbis Holdings
1,324.00
-99.12
-6.96%
JP:4527
Rohto Pharmaceutical Co
2,560.50
-81.82
-3.10%
JP:4928
Noevir Holdings Co., Ltd.
4,565.00
-93.12
-2.00%

Lion Corporate Events

Lion Corporation Reports Strong Financial Growth for Nine Months Ending September 2025
Nov 7, 2025

Lion Corporation reported a significant increase in its financial performance for the nine months ending September 30, 2025, with net sales reaching ¥304,945 million, a 1.3% increase year-on-year. The company’s operating profit surged by 62.7% to ¥27,829 million, and profit before tax rose by 52.2% to ¥29,797 million. This robust growth is attributed to improved core operating income and effective cost management. The company’s financial position remains strong with a notable increase in equity attributable to owners of the parent, reflecting a solid balance sheet. The dividend forecast for fiscal 2025 indicates a potential increase, suggesting confidence in continued financial stability and growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025